Stereotaxis Wins FDA Clearance for Synchrony System: Stereotaxis cleared by FDA on Apr 6, 2026; STXS stock moved up ~8% intraday. Synchrony targets the U.S. ablation market with ~100k–150k annual AF procedures. 👈 Read full analysis #Stereotaxis #FDAClearance #SynchronySystem #CatheterAblation #STXS
Catheter ablation as first-line therapy for AF—clinical implications.
www.scienceopen.com/hosted-docum...
#AtrialFibrillation #CatheterAblation #Arrhythmia #CardioSky #MedSky
📣Review Sharing: Volume 86, Issue 9
🧾Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure—Therapy or Futility?
👩🔬Yael Ben-Baruch Golan,Pier D Lambiase
💡Full Text: magonlinelibrary.com/doi/full/10....
#HeartFailure #Atrialfibrillation #InternalMeicine #Catheterablation
A commentary discussing the use of #CatheterAblation as first-line therapy for selected patients with #AtrialFibrillation and #HeartFailure, covering current guidelines, limitations, and future perspectives. #CVIA
#OpenAccess: tinyurl.com/28a6la8o
🚨 NEW RESEARCH! ⚕️ 🩺
Lin et al. identify the optimal timing for atrial fibrillation patients to undergo catheter ablation as less than 3 years. 🫀
https://bit.ly/3GrWI75
#HeartHealth #CatheterAblation
AI Pinpoints Irregular Heart Rhythms to Improve Atrial Fibrillation Treatment 💓🤖📈 www.azoai.com/news/2025042... #AtrialFibrillation #nMedicine #Cardiology #Heart #Health #MedicalInnovation #Electrophysiology #CatheterAblation #Healthcare #AI #Arrhythmia
Advancements in #atrialfibrillation therapy highlight #catheterablation as a key treatment, especially for select patients and those with heart failure.
Read More: cvia-journal.org/catheter-abl...
#firstline #earlyablation #Cardiology #CardioEd #CVIA #CVIAJournal @scienceopen.bsky.social
Great take aways from the debate.
Who do you think should get #CatheterAblation for #AFib?